Showing 8021-8030 of 10617 results for "".
- RRM Study Suggests Lower Breast Cancer Mortality Riskhttps://reachmd.com/news/rrm-study-suggests-lower-breast-cancer-mortality-risk/2457227/A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women's College Hospital, finds risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant, significantly
- Identifying Immunotherapy Resistance in Liver Cancer Linked to Steatotic Diseasehttps://reachmd.com/news/identifying-immunotherapy-resistance-in-liver-cancer-linked-to-steatotic-disease/2457202/A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease. The findin
- Hackensack Meridian Health Biologist-Turned-Med Student Publishes COVID-19 Vaccine Studyhttps://reachmd.com/news/hackensack-meridian-health-biologist-turned-med-student-publishes-covid-19-vaccine-study/2457179/First-year Hackensack Meridian School of Medicine (HMSOM) student Elizabeth Titova leveraged her background in phlebotomy and scientific research to publish a new clinical study around COVID-19 vaccination in Microbiology Spectrum, a peer-reviewed, open-access ASM J
- New Year Brought Increased Consumer Interest in Food and Nutrition Resolutionshttps://reachmd.com/news/new-year-brought-increased-consumer-interest-in-food-and-nutrition-resolutions/2457198/Survey also shows food expenditures 20% higher than last January WEST LAFAYETTE, Ind. — Food or nutrition-related New Year’s resolutions were more popular among consumers going into 2024 compared to last year, according to the
- Blood-Based Biomarker Test Highly Effective At Identifying Those at Risk of Developing Parkinson Diseasehttps://reachmd.com/news/blood-based-biomarker-test-highly-effective-at-identifying-those-at-risk-of-developing-parkinson-disease/2457174/Study results published in JAMA Neurology demonstrated an association between elevated L1CAM-positive extracellular vesicle (L1EV) α-synuclein serum levels and the risk of developing Parkinson disease (PD) or related dementia. The retrospective, cross
- Visualizing Multiple Sclerosis with a New MRI Procedurehttps://reachmd.com/news/visualizing-multiple-sclerosis-with-a-new-mri-procedure/2457126/Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone. One key feature of the disease is that it causes the patient’s own immune system to attack and dest
- ResearchPharmacological Inhibitor Protects Nerve Cells in ALS Diseasehttps://reachmd.com/news/researchpharmacological-inhibitor-protects-nerve-cells-in-als-disease/2457127/ALS is a degenerative disease of the nervous system particularly affecting and harmful to motor neurons. As the disease progresses, the nerve cells controlling voluntary muscle movement die. That leads to a progressive wasting of the muscles responsible for moving and speaking, but also
- New Drug Could Prevent Diabetic Eye and Kidney Disease in People With Diabeteshttps://reachmd.com/news/new-drug-could-prevent-diabetic-eye-and-kidney-disease-in-people-with-diabetes/2457098/New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in
- Physical Activity Is Insufficient to Counter Cardiovascular Risk Associated with Sugar-Sweetened Beverage Consumptionhttps://reachmd.com/news/physical-activity-is-insufficient-to-counter-cardiovascular-risk-associated-with-sugar-sweetened-beverage-consumption/2457113/Québec, February 8, 2024 – Contrary to popular belief, the benefits of physical activity do not outweigh the risks of cardiovascular disease associated with drinking sugar-sweetened beverages, according to a new study led by Harvard T. H. Chan School of Public Health. Jean-Philippe Dr
- Blood Test Predicts Psychosis Risk, Most Effective Treatmentshttps://reachmd.com/news/blood-test-predicts-psychosis-risk-most-effective-treatments/2457133/INDIANAPOLIS — A team of researchers led by Indiana University School of Medicine faculty have developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions. Schizophrenia and related psychotic disorders affect o